IBDEI25Y ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34543,2)
 ;;=^5003400
 ;;^UTILITY(U,$J,358.3,34544,0)
 ;;=F18.959^^134^1751^15
 ;;^UTILITY(U,$J,358.3,34544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34544,1,3,0)
 ;;=3^Inhalant Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,34544,1,4,0)
 ;;=4^F18.959
 ;;^UTILITY(U,$J,358.3,34544,2)
 ;;=^5003412
 ;;^UTILITY(U,$J,358.3,34545,0)
 ;;=F18.99^^134^1751^22
 ;;^UTILITY(U,$J,358.3,34545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34545,1,3,0)
 ;;=3^Inhalant Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,34545,1,4,0)
 ;;=4^F18.99
 ;;^UTILITY(U,$J,358.3,34545,2)
 ;;=^5133360
 ;;^UTILITY(U,$J,358.3,34546,0)
 ;;=F18.21^^134^1751^25
 ;;^UTILITY(U,$J,358.3,34546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34546,1,3,0)
 ;;=3^Inhalant Use D/O,Mod/Sev,In Remission
 ;;^UTILITY(U,$J,358.3,34546,1,4,0)
 ;;=4^F18.21
 ;;^UTILITY(U,$J,358.3,34546,2)
 ;;=^5003393
 ;;^UTILITY(U,$J,358.3,34547,0)
 ;;=F18.11^^134^1751^24
 ;;^UTILITY(U,$J,358.3,34547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34547,1,3,0)
 ;;=3^Inhalant Use D/O,Mild,In Remission
 ;;^UTILITY(U,$J,358.3,34547,1,4,0)
 ;;=4^F18.11
 ;;^UTILITY(U,$J,358.3,34547,2)
 ;;=^5151305
 ;;^UTILITY(U,$J,358.3,34548,0)
 ;;=Z00.6^^134^1752^1
 ;;^UTILITY(U,$J,358.3,34548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34548,1,3,0)
 ;;=3^Exam Control in Clinical Research
 ;;^UTILITY(U,$J,358.3,34548,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,34548,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,34549,0)
 ;;=F45.8^^134^1753^13
 ;;^UTILITY(U,$J,358.3,34549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34549,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,34549,1,4,0)
 ;;=4^F45.8
 ;;^UTILITY(U,$J,358.3,34549,2)
 ;;=^331915
 ;;^UTILITY(U,$J,358.3,34550,0)
 ;;=F45.0^^134^1753^12
 ;;^UTILITY(U,$J,358.3,34550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34550,1,3,0)
 ;;=3^Somatization D/O
 ;;^UTILITY(U,$J,358.3,34550,1,4,0)
 ;;=4^F45.0
 ;;^UTILITY(U,$J,358.3,34550,2)
 ;;=^112280
 ;;^UTILITY(U,$J,358.3,34551,0)
 ;;=F45.9^^134^1753^14
 ;;^UTILITY(U,$J,358.3,34551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34551,1,3,0)
 ;;=3^Somatoform Symp & Rel D/O,Unspec
 ;;^UTILITY(U,$J,358.3,34551,1,4,0)
 ;;=4^F45.9
 ;;^UTILITY(U,$J,358.3,34551,2)
 ;;=^5003592
 ;;^UTILITY(U,$J,358.3,34552,0)
 ;;=F45.1^^134^1753^11
 ;;^UTILITY(U,$J,358.3,34552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34552,1,3,0)
 ;;=3^Somatic Symptom D/O
 ;;^UTILITY(U,$J,358.3,34552,1,4,0)
 ;;=4^F45.1
 ;;^UTILITY(U,$J,358.3,34552,2)
 ;;=^5003585
 ;;^UTILITY(U,$J,358.3,34553,0)
 ;;=F44.4^^134^1753^4
 ;;^UTILITY(U,$J,358.3,34553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34553,1,3,0)
 ;;=3^Conversion D/O w/ Motor Symp or Deficit
 ;;^UTILITY(U,$J,358.3,34553,1,4,0)
 ;;=4^F44.4
 ;;^UTILITY(U,$J,358.3,34553,2)
 ;;=^5003579
 ;;^UTILITY(U,$J,358.3,34554,0)
 ;;=F44.6^^134^1753^1
 ;;^UTILITY(U,$J,358.3,34554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34554,1,3,0)
 ;;=3^Conversion D/O w/ Anesthesia or Sensory Loss
 ;;^UTILITY(U,$J,358.3,34554,1,4,0)
 ;;=4^F44.6
 ;;^UTILITY(U,$J,358.3,34554,2)
 ;;=^5003581
 ;;^UTILITY(U,$J,358.3,34555,0)
 ;;=F44.5^^134^1753^2
 ;;^UTILITY(U,$J,358.3,34555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34555,1,3,0)
 ;;=3^Conversion D/O w/ Attacks or Seizures
 ;;^UTILITY(U,$J,358.3,34555,1,4,0)
 ;;=4^F44.5
 ;;^UTILITY(U,$J,358.3,34555,2)
 ;;=^5003580
 ;;^UTILITY(U,$J,358.3,34556,0)
 ;;=F44.7^^134^1753^3
